Search the collection

49 results for Lapatinib+-+therapeutic+use

Sort by:

Sort by

Limit results to:

20 per page

49 results for Lapatinib+-+therapeutic+use

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade
Author / Creator:Brasó-Maristany, Fara ; Griguolo, Gaia ; Pascual, Tomás ; Paré, Laia ; Nuciforo, Paolo ; Llombart-Cussac, Antonio ; Bermejo, Begoña ; Oliveira, Mafalda ; Morales, Serafín ; Martínez, Noelia ; Vidal, Maria ; Adamo, Barbara ; Martínez, Olga ; Pernas, Sonia ; López, Rafael ; Muñoz, Montserrat ; Chic, Núria ; Galván, Patricia ; Garau, Isabel ; Manso, Luis ; Alarcón, Jesús ; Martínez, Eduardo ; Gregorio, Sara ; Gomis, Roger R. ; Villagrasa, Patricia ; Cortés, Javier ; Ciruelos, Eva ; Prat, Aleix
Publisher:London: Nature Publishing Group UK
Journal title:Nature communications, 2020-01, Vol.11 (1), p.385-385, Article 385
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): patient-reported outcomes from a randomised, open-label, multi...
Author / Creator:Fehm, Tanja, Prof ; Cottone, Francesco, PhD ; Dunton, Kyle, MSc ; André, Fabrice, MD ; Krop, Ian, MD ; Park, Yeon Hee, MD ; De Laurentiis, Michelino, MD ; Miyoshi, Yasuo, MD ; Armstrong, Anne, MBChB ; Borrego, Manuel Ruiz, MD ; Yerushalmi, Rinat, MD ; Duhoux, Francois P, MD ; Takano, Toshimi, MD ; Lu, Wenjing, PhD ; Egorov, Anton, MD ; Kim, Sung-Bae, MD
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2024-05, Vol.25 (5), p.614-625
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures
Author / Creator:Vander Velde, Robert ; Yoon, Nara ; Marusyk, Viktoriya ; Durmaz, Arda ; Dhawan, Andrew ; Miroshnychenko, Daria ; Lozano-Peral, Diego ; Desai, Bina ; Balynska, Olena ; Poleszhuk, Jan ; Kenian, Liu ; Teng, Mingxiang ; Abazeed, Mohamed ; Mian, Omar ; Tan, Aik Choon ; Haura, Eric ; Scott, Jacob ; Marusyk, Andriy
Publisher:London: Nature Publishing Group UK
Journal title:Nature communications, 2020-05, Vol.11 (1), p.2393-13, Article 2393
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
Combination treatment with a PI3K/Akt/mTOR pathway inhibitor overcomes resistance to anti-HER2 therapy in PIK3CA-mutant HER2-positive breast cancer cells
Author / Creator:Fujimoto Yumi ; Morita, Tomoko Yamamori ; Ohashi Akihiro ; Haeno Hiroshi ; Hakozaki Yumi ; Fujii Masanori ; Kashima Yukie ; Kobayashi, Susumu S ; Mukohara Toru
Publisher:London: Nature Publishing Group
Journal title:Scientific reports, 2020-12, Vol.10 (1)
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)
Author / Creator:Hurvitz, Sara A. ; Caswell-Jin, Jennifer L. ; McNamara, Katherine L. ; Zoeller, Jason J. ; Bean, Gregory R. ; Dichmann, Robert ; Perez, Alejandra ; Patel, Ravindranath ; Zehngebot, Lee ; Allen, Heather ; Bosserman, Linda ; DiCarlo, Brian ; Kennedy, April ; Giuliano, Armando ; Calfa, Carmen ; Molthrop, David ; Mani, Aruna ; Chen, Hsiao-Wang ; Dering, Judy ; Adams, Brad ; Kotler, Eran ; Press, Michael F. ; Brugge, Joan S. ; Curtis, Christina ; Slamon, Dennis J.
Publisher:London: Nature Publishing Group UK
Journal title:Nature communications, 2020-11, Vol.11 (1), p.5824-15, Article 5824
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
ArticlesPeer ReviewedFull Text
Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metasta...
Author / Creator:Dai, Ming Shen ; Feng, Yin Hsun ; Chen, Shang Wen ; Masuda, Norikazu ; Yau, Thomas ; Chen, Shou Tung ; Lu, Yen Shen ; Yap, Yoon Sim ; Ang, Peter C. S. ; Chu, Sung Chao ; Kwong, Ava ; Lee, Keun Seok ; Ow, Samuel ; Kim, Sung Bae ; Lin, Johnson ; Chung, Hyun Cheol ; Ngan, Roger ; Kok, Victor C. ; Rau, Kun Ming ; Sangai, Takafumi ; Ng, Ting Ying ; Tseng, Ling Ming ; Bryce, Richard ; Bebchuk, Judith ; Chen, Mei Chieh ; Hou, Ming Feng
Publisher:New York: Springer US
Journal title:Breast cancer research and treatment, 2021-10, Vol.189 (3), p.665-676
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 7
ArticlesPeer ReviewedFull Text
Lapatinib antitumor effect is associated with PI3K and MAPK pathway: An analysis in human and canine prostate cancer cells
Author / Creator:Fonseca-Alves, Carlos Eduardo ; Leis-Filho, Antonio Fernando ; Lacerda, Zara Alves ; de Faria Lainetti, Patricia ; Amorim, Renee Laufer ; Rogatto, Silvia Regina
Publisher:United States: Public Library of Science
Journal title:PloS one, 2024-04, Vol.19 (4), p.e0297043-e0297043
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 8
ArticlesPeer ReviewedFull Text
Mechanisms and potential interventions associated with the cardiotoxicity of ErbB2-targeted drugs: Insights from in vitro, in vivo, and clinical studies in breast cancer patients
Author / Creator:Leemasawat Krit ; Arintaya, Phrommintikul ; Chattipakorn, Siriporn C ; Chattipakorn Nipon
Publisher:Basel: Springer Nature B.V
Journal title:Cellular and molecular life sciences : CMLS, 2020-04, Vol.77 (8), p.1571-1589
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 9
ArticlesPeer ReviewedFull Text
INHBA is a mediator of aggressive tumor behavior in HER2+ basal breast cancer
Author / Creator:Liu, Moqing ; Smith, Rebecca ; Liby, Tiera ; Chiotti, Kami ; López, Claudia S. ; Korkola, James E.
Publisher:England: BioMed Central Ltd
Journal title:Breast cancer research : BCR, 2022-03, Vol.24 (1), p.18-18, Article 18
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 10
ArticlesPeer ReviewedFull Text
Pyrotinib versus lapatinib therapy for HER2 positive metastatic breast cancer patients after first-line treatment failure: A meta-analysis and systematic review
Author / Creator:Yuan, Ye ; Liu, Xumei ; Cai, Yi ; Li, Wenyuan
Publisher:United States: Public Library of Science
Journal title:PloS one, 2023-01, Vol.18 (1), p.e0279775
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 11
ArticlesPeer ReviewedFull Text
Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs
Author / Creator:Maeda, Shingo ; Sakai, Kosei ; Kaji, Kenjiro ; Iio, Aki ; Nakazawa, Maho ; Motegi, Tomoki ; Yonezawa, Tomohiro ; Momoi, Yasuyuki
Publisher:London: Nature Publishing Group UK
Journal title:Scientific reports, 2022-01, Vol.12 (1), p.4-4, Article 4
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 12
ArticlesPeer ReviewedFull Text
Lysosomal Destabilizing Drug Siramesine and the Dual Tyrosine Kinase Inhibitor Lapatinib Induce a Synergistic Ferroptosis through Reduced Heme Oxygenase-1 (HO-1) Levels
Author / Creator:Gibson, Spencer ; Konzelman, Carmen ; Blankstein, Anna R. ; Villalpando-Rodriguez, Gloria E.
Publisher:Cairo, Egypt: Hindawi Publishing Corporation
Journal title:Oxidative medicine and cellular longevity, 2019, Vol.2019 (2019), p.1-14
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 13
ArticlesPeer ReviewedFull Text
Cost-utility and budget impact analysis of neoadjuvant dual HER2 targeted therapy for HER2-positive breast cancer in Sri Lanka
Author / Creator:Gunasekara, Agampodi Danushi Mendis ; Youngkong, Sitaporn ; Anothaisintawee, Thunyarat ; Dejthevaporn, Thitiya ; Fernandopulle, Rohini ; Chaikledkaew, Usa
Publisher:London: Nature Publishing Group UK
Journal title:Scientific reports, 2024-07, Vol.14 (1), p.16736-13, Article 16736
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 14
ArticlesPeer ReviewedFull Text
Outcomes and Prognostic Factors in HER2-Positive Metastatic Breast Cancer Patients Who Had Developed Brain Metastasis in the Treatment Process
Author / Creator:Dogan, Izzet ; Kizildag, Inci ; Özkurt, Selnur ; Ibis, Kamuran ; Vatansever, Sezai ; Saip, Pinar ; Aydiner, Adnan
Publisher:Basel, Switzerland: S. Karger AG
Journal title:Oncology, 2023-04, Vol.101 (4), p.262-269
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 15
ArticlesPeer ReviewedFull Text
A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL stud...
Author / Creator:Patel, Tejal A. ; Ensor, Joe E. ; Creamer, Sarah L. ; Boone, Toniva ; Rodriguez, Angel A. ; Niravath, Poly A. ; Darcourt, Jorge G. ; Meisel, Jane L. ; Li, Xiaoxian ; Zhao, Jing ; Kuhn, John G. ; Rosato, Roberto R. ; Qian, Wei ; Belcheva, Anna ; Schwartz, Mary R. ; Kaklamani, Virginia G. ; Chang, Jenny C.
Publisher:England: BioMed Central Ltd
Journal title:Breast cancer research : BCR, 2019-09, Vol.21 (1), p.100-9, Article 100
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 16
ArticlesPeer ReviewedFull Text
Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-la...
Author / Creator:Hickish, Tamas ; Mehta, Ajay ; Liu, Mei-Ching ; Huang, Chiun-Sheng ; Arora, Rajendra Singh ; Chang, Yuan-Ching ; Yang, Youngsen ; Vladimirov, Vladimir ; Jain, Minish ; Tsang, Janice ; Pemberton, Karine ; Sadrolhefazi, Behbood ; Jin, Xidong ; Tseng, Ling-Ming
Publisher:New York: Springer US
Journal title:Breast cancer research and treatment, 2022-04, Vol.192 (3), p.593-602
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 17
ArticlesPeer ReviewedFull Text
High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer
Author / Creator:Normann, Lisa Svartdal ; Haugen, Mads Haugland ; Hongisto, Vesa ; Aure, Miriam Ragle ; Leivonen, Suvi-Katri ; Kristensen, Vessela N. ; Tahiri, Andliena ; Engebraaten, Olav ; Sahlberg, Kristine Kleivi ; Mælandsmo, Gunhild Mari
Publisher:United States: Public Library of Science
Journal title:PloS one, 2023-01, Vol.18 (1), p.e0280507
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 18
ArticlesPeer ReviewedFull Text
Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review
Author / Creator:Canino, Fabio ; Piacentini, Federico ; Omarini, Claudia ; Toss, Angela ; Barbolini, Monica ; Vici, Patrizia ; Dominici, Massimo ; Moscetti, Luca
Publisher:Switzerland: MDPI AG
Journal title:International journal of molecular sciences, 2022-06, Vol.23 (13), p.7079
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 19
ArticlesPeer ReviewedFull Text
Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase
Author / Creator:Jathal, Maitreyee K ; Steele, Thomas M ; Siddiqui, Salma ; Mooso, Benjamin A ; Leandro S D’Abronzo ; Drake, Christiana M ; Whang, Young E ; Ghosh, Paramita M
Publisher:London: Nature Publishing Group
Journal title:British journal of cancer, 2019-07, Vol.121 (3), p.237-248
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 20
ArticlesPeer ReviewedFull Text
EB1089 Increases the Antiproliferative Response of Lapatinib in Combination with Antiestrogens in HER2-Positive Breast Cancer Cells
Author / Creator:Achounna, Angèle Sorel ; Ordaz-Rosado, David ; García-Quiroz, Janice ; Morales-Guadarrama, Gabriela ; Milo-Rocha, Edgar ; Larrea, Fernando ; Díaz, Lorenza ; García-Becerra, Rocío
Publisher:Switzerland: MDPI AG
Journal title:International journal of molecular sciences, 2024-03, Vol.25 (6), p.3165
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Showing 1 to 20 of 49 results

Export record to excel

Export this record

Export record to excel

Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade

Export this record

Export record to excel

Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): patient-reported outcomes from a randomised, open-label, multi...

Export this record

Export record to excel

Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures

Export this record

Export record to excel

Combination treatment with a PI3K/Akt/mTOR pathway inhibitor overcomes resistance to anti-HER2 therapy in PIK3CA-mutant HER2-positive breast cancer cells

Export this record

Export record to excel

Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)

Export this record

Export record to excel

Analysis of the pan-Asian subgroup of patients in the NALA Trial: a randomized phase III NALA Trial comparing neratinib+capecitabine (N+C) vs lapatinib+capecitabine (L+C) in patients with HER2+metasta...

Export this record

Export record to excel

Lapatinib antitumor effect is associated with PI3K and MAPK pathway: An analysis in human and canine prostate cancer cells

Export this record

Export record to excel

Mechanisms and potential interventions associated with the cardiotoxicity of ErbB2-targeted drugs: Insights from in vitro, in vivo, and clinical studies in breast cancer patients

Export this record

Export record to excel

INHBA is a mediator of aggressive tumor behavior in HER2+ basal breast cancer

Export this record

Export record to excel

Pyrotinib versus lapatinib therapy for HER2 positive metastatic breast cancer patients after first-line treatment failure: A meta-analysis and systematic review

Export this record

Export record to excel

Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs

Export this record

Export record to excel

Lysosomal Destabilizing Drug Siramesine and the Dual Tyrosine Kinase Inhibitor Lapatinib Induce a Synergistic Ferroptosis through Reduced Heme Oxygenase-1 (HO-1) Levels

Export this record

Export record to excel

Cost-utility and budget impact analysis of neoadjuvant dual HER2 targeted therapy for HER2-positive breast cancer in Sri Lanka

Export this record

Export record to excel

Outcomes and Prognostic Factors in HER2-Positive Metastatic Breast Cancer Patients Who Had Developed Brain Metastasis in the Treatment Process

Export this record

Export record to excel

A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL stud...

Export this record

Export record to excel

Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-la...

Export this record

Export record to excel

High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer

Export this record

Export record to excel

Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review

Export this record

Export record to excel

Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase

Export this record

Export record to excel

EB1089 Increases the Antiproliferative Response of Lapatinib in Combination with Antiestrogens in HER2-Positive Breast Cancer Cells

Refine your search